Would you consider a combination of anti-TNF therapy and azathioprine upfront in a young male with Crohn’s disease considering its risk of lymphoma in the era of several advanced therapies?
1 Answers
Mednet Member
Gastroenterology · Northwestern Medicine
Definitely, TNF + IMM hasn’t been beaten in efficacy. If the patient is in clinical and endoscopic remission at 6-12 months with good IFX levels, then they can stop the IMM.
Would you consider a combination of anti-TNF therapy and azathioprine upfront in a young male with Crohn’s disease considering its risk of lymphoma in the era of several advanced therapies? | Mednet
